chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv Td instead of PPD & exp wide spread redness, itching & pain @ test site;disappeared in 48-72hr p/vax w/cold packs & in some cases topical hydrocortisone cream was applied;
A legal complaint was received from an attorney alleging that a male child received Tetramune vaccine on 7/7/98. The child received a series of D.T.P. vaccine from 3/9/98 through 7/1/99 and Engerix B from 2/12/98 through 7/7/98 and subsequently "suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via IM injections of mercury" in the "thimerosal-containing vaccinations." According to the legal complaint, the child "was born a perfectly normal, healthy boy whose APGAR scores at birth were well within the normal range." It is alleged that at approximately 24 months of age, the child "was neurologically devastated by the accumulation of mercury in his body, having been exposed via IM vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills." According to the legal complaint, the child "suffered severe and permanent injuries" and "sustained and will sustain in the future a mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." Vaccination info contained in the legal complaint indicated that the child received D.T.P vaccine beyond 12 months of age.
Next day after vaccine had diarrhea, total body aches and chills. Wed. night 10/20/10 had fever (no temp taken) warm to touch, chills. Called doctor 10/21/10 instructed to take TYLENOL. Then c/o sore throat, chills, deep ache in joints. Called doctor in pm. on 10/21/10. Alternate TYLENOL/MOTRIN missed work - 10/22/10.
PATIENT HAS BEEN EXPERIENCING MUSCLE PAIN AT SITE OF INJECTION, INJECTION SITE PAIN, AND SKIN SENSITIVITY SIMILAR TO HER EXPERIENCES OF HERPES OUTBREAKS.
Patient felt warm at supper time. He was afebrile prior to this. His eye then rolled back and he had tonic/clonic movements of extremities common with seizure activity. Temperature 102. This was a febrile seizure occurrence. The medical record received on 1/8/04 states strep pharyngitis.
Myalgia, Arthralgia, chills, fatigue Narrative:  Myalgia, Arthralgia, chills, fatigue; taking ibuprofen
exhaustion; joint pain; fever; This is a spontaneous report from a contactable consumer reported for a patient (Cousin's wife). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced exhaustion, joint pain and fever. Reported need to report two instances of adverse side effects that was told by a family member that received the 2nd dose of the Covid-19 vaccination. Reporter cousin's wife received the 2nd dose in (State name). Reporter cousin let reporter know that his wife, who had MS, experienced: exhaustion, joint pain and fever. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Myasthenic Crisis. Hospitalized. Immediately after shot got headache/still have it. Extreme tiredness day after shot which continued throughput. Got Short of Breath around day 9. Was sent to ER by ambulance from Urgent Care. Was close to being intubated.Was in SICU 7 days,  then 2 days regular hospital room.  Am still  very tired and weak and short of breath with weak diaphragm and will ho back to ER if no improvement.
first shot of Pfizer Covid vaccine two and half weeks ago on Jan2021 but now he is positive with Covid; first shot of Pfizer Covid vaccine two and half weeks ago on Jan2021 but now he is positive with Covid; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient was diagnosed on 02Feb2021 with COVID. He tested positive and had his first shot of Pfizer Covid vaccine two and half weeks ago on Jan2021 but now he is positive with Covid. He was definitely quarantined for 10 days but (incomplete sentence). Reporter was asking why did he get sick after getting the first shot. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Administered Hep A shot on 2/27/2015. On 3/3/2015, patient called with itching and redness at the site. 3/4/2015 called with redness and warmth increasing. On3/25/15, patient treated for cellulitis.
Patient woke 10:30 pm 12/7/03 with itching between fingers, on wrists and arms.  Today 12/12 is also itching and rash between thighs.  Denies any problems  with breathing or swallowing.  Denies any egg allergy, drug allergy, or environmental allergy
Developed rash that has been spreading since 4/11/2021. My primary care physician prescribed famotidine, loratadine and prednisone on 4/19/2021; and suggested I report this as a possible adverse reaction to the Moderna vaccine.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 16-DEC-2014, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 13-NOV-2016, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe varicella pneumonia. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Upon internal review, varicella pneumonia was determined a significant medical event. Additional information has been requested.
Patient is fully vaccinated. COVID positive at ED visit on 4/20/2022. 26-year-old female presents to the ED complaining of 1 day of sore throat, cough, subjective fever.No chest pain or shortness of breath.  Her cough is nonproductive.  No rhinorrhea or earache.  No abdominal pain nausea vomiting diarrhea or dysuria. Positive for fever. Strep test negative.  Chest x-ray negative for acute process.  She is breathing comfortably on room air, no respiratory distress. Discharged home.
9 days after administration of MMR and Varicella vaccines developed fever to 100.8 and maculopapular rash starting on face and progressing down neck, chest, arms.
Patient was given Moderna vaccine on 10/4/2021. The shelf life of the vaccine expired on 10/3/21. The vaccine was not expired
Patient was given the COVID 19 Bivalent Booster past the Beyond Use Date. The BUD date was 01/13/2023.  The patient received the vaccine on 01/27/2023.
I woke up the next morning with the COVID arm .  Large RED swollen patch directly under the injection site
PATIENT PASSED OUT BRIEFLY AND FELL SHORTLY AFTER VACCINATION.  SHE HIT HER FOREHEAD AND WAS FEELING DIZZY AND NAUSEOUS FOR A LITTLE WHILE.  HER BOYFRIEND CALLED THE AMBULANCE AND PARAMEDICS ARRIVED  SHORTLY AFTER.  THEY CHECKED HER VITALS AND FOUND HER BLOOD PAS A LITTLE LOW.  THEY MONITORED AND OBSERVED HER FOR A LITTLE WHILE AND DETERMINED THAT SHE WAS OK.  PATIENT LEFT THE PHARMACY AFTER RESTING.
States the told him to buy a medication for allergies because of his nose.  Caller states the medication did not work.; Difficulty swallowing and feels like he will suffocate; Difficulty swallowing and feels like he will suffocate; suspected covid-19; drug ineffective; Dry mouth; Tongue has white thing over it; Loss of the sense of taste; Difficulty perceiving smells; Fever-like sensation sporadically; Fever; his mouth is sore; Difficulty eating; This is a spontaneous report received from a contactable consumer (patient).   A 40-years-old male patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot Number: GR8734), via an unspecified route of administration on 16Apr2021 (age at vaccination 40 years) as dose 2, single and first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EP7534) via an unspecified route of administration on 26Mar2021 (age at vaccination 40 years) as dose 1, single for covid-19 immunisation. There was no patient's medical History (including any illness at time of vaccination). There were no concomitant medications. After the second vaccination the patient stated that the he has had several side effects. In mar2021, the patient experienced suspected covid-19 and for whom reported drug ineffective. The patient sometimes has a fever, difficulty smelling things, fever-like sensation sporadically, his tongue has a white thing over it, he has lost his sense of taste, and his mouth was sore and dry. The patient states that he cannot put exact dates on his symptoms. The patient said the fever comes and goes, then comes back again. He stated that difficulty smelling things began with the first dose of the vaccine and has not stopped. The patient states that he still has this symptom and tongue has white thing over it/loss of taste it is the worst one. Patient said it makes it difficult to eat and he cannot taste anything. The patient stated mouth was dry and sore he still has this symptoms as well. stated that sometimes his mouth gets so dry he has difficulty swallowing and feels like he will suffocate. The patient stated that since he had the first vaccine he has felt like he has Covid 19. The patient thinks he got vaccines in right arm but is not certain. There was no adverse events following prior vaccinations. The patient states that he has only spoke with the pharmacy about his symptoms. States the told him to buy a medication for allergies because of his nose. The patient states the medication did not work. The patient was recommended by the pharmacy to take some allergy medications (treatment). Also states allergy medication did not work. The outcome of events reported as not recovered for dry mouth, tongue has white thing over it, loss of the sense of taste, difficulty perceiving smells, fever, his mouth is sore, since he had the first vaccine he has felt like he has covid 19, difficulty eating, difficulty swallowing and feels like he will suffocate and allergy and unknown for fever-like sensation sporadically and suspected covid-19.  Follow-up attempts are completed. No further information was expected.
This solicited report has been received from a mother's patient friend, as part of a market research program, concerning to an unknown female patient. The patient's concurrent condition, historical conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL (dose and frequency not reported). It was reported that an interview was performed to the patient's mother friend who said that before she and her daughter was taking the vaccine a friend told them that her daughter passed out after getting it (Loss of consciousness). The outcome of the event was reported as unknown. The causality between the event loss of consciousness and therapy with GARDASIL was not reported. Upon internal review, loss of consciousness was considered medically significant. Additional information is not expected as the reporter did not consent for further follow up.
Fever, aches pain and chills all night day of shot.  Achy, fatigue and fever Monday and Tuesday (so far) after shot on Sunday
Received vaccine on 10/29/13 - and about 2.5 h after she started with sudden onset of generalized headache (less on forehead), had some nausea - no vomiting, treated with ibuprofen 400 mg  - poor response; no fever or body aching, no rash. She had some sore throat but resolved with ibuprofen. HA lasted until time she fell asleep on 10/30/13 at night. Woke up fine on 10/31/13.
covid; covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old patient received BNT162b2 (BNT162B2), on 26Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 19Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 03Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL SULFATE]. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (08May2022) Negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical Course: Patient received other medication in 2 weeks, product was Albuteral inhaler. Rapid test was negative on Sunday 08May2022. Started to have Covid symptoms again on 16May2022. Took another rapid test and showed positive. Sinus issues. Patient believe was contagious with second flair up because now the patients sister tested positive on 19May2022. No Known allergies. Other medical history include asthma. Treatment drug included Paxlovid from 02May2022 to 06May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a pharmacist concerning a patient of unknown age and gender, who on 19-SEP-2012 was vaccinated with a dose of PNEUMOVAX 23 (dose and route not reported) (lot # 667912/0933Z, Exp: 25-FEB-2012). No symptoms reported. Additional information has been requested.
Initial report was received from a health care professional on 11 February 2011. A 14 year-old female with allergies to penicillin and CECLOR had received an intramuscular right deltoid injection of MENACTRA, lot number U3098AA in the AM on 09 February 2011 and that PM, experienced generalized body aches and pains, stomach pain, nausea, joint pain, dilated eyes and was reported to be off balance. The patient was evaluated by her primary care physician. Treatments were not reported. The patient did not have any concomitant medications. No further information was available at the time of the report. The patient's outcome was recovered (date not reported). Documents held by sender: none.
LIGHT-HEADED AND DIZZY; BODY ACHE; LEFT LEG THROBBING; INCREASE HEART RATE; HIGH BLOOD PRESSURE; NAUSEOUS; FEVER; HEART RACING; CHILLS; WEAKNESS; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 11:30 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced heart racing. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced weakness. On 07-APR-2021, the subject experienced increase heart rate. On 07-APR-2021, the subject experienced high blood pressure. On 07-APR-2021, the subject experienced light-headed and dizzy. On 07-APR-2021, the subject experienced body ache. On 07-APR-2021, the subject experienced left leg throbbing. On 07-APR-2021, the subject experienced nauseous. On 07-APR-2021, the subject experienced fever. Laboratory data included: Blood pressure (NR: not provided) 130/105 mmHg, and Heart rate (NR: not provided) 110bpm. On 08-APR-2021, Laboratory data included: Blood pressure (NR: not provided) 140/103 bpm, and Body temperature (NR: not provided) 99.5 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from increase heart rate, and had not recovered from light-headed and dizzy, nauseous, body ache, fever, high blood pressure, left leg throbbing, weakness, heart racing, and chills. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.
Tinnitus - new intermittent loud ringing in right ear not previously experienced prior to first or second shot of Pfizer-BioNTech COVID-19 shot.
DIARRHEA; VOMITING; HEADACHE; This spontaneous report received from a consumer concerned a 7 decade old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 26-MAR-2021, the subject experienced diarrhea. On 26-MAR-2021, the subject experienced vomiting. On 26-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, vomiting, and headache on 27-MAR-2021. This report was non-serious.
Immediately after injection felt fatigue, dry throat, tightness in face. Sx. persisted x 2 days. Called PCP, no response. Needed no treatment. No fever, chills, HA, myalgias.
Fever to 102, chills, body aches. Palpitations headache, nausea everything started the day after symptoms lasted until 3/2/2021
Headache, Myalgia, Arthralgia, Fever, joint and muscle aches H/A lymphadenopathy axilla side of inj, fever 102-104 Narrative:
I was real cold; I'm just tired; I don't want to do anything; I'm fast breathing heartbeat; Dizziness; Shortness of breath; This is a spontaneous report from a contactable consumer (Patient). A 77-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: 0176 (Not clarified); expiration date: unknown), via an unspecified route of administration on 28May2021 as 2nd dose, single dose for COVID-19 immunization. The patient historical vaccine included first dose of BNT162B2 on 07May2021 for COVID-19 immunization. The medical history and concomitant medications were not reported. The patient reported, received the second vaccine this Friday and having effects more than got with the first one. Patient was asking if that was normal or not. Patient had side effects that didn't had with the first shot. Patient stated, Dizziness, was fast breathing heartbeat. Patient did not experience any of this with the first shot, it was the second shot. Dizziness and just like patient said shortness of breath and had chills too and patient just tired, chills and tiredness and didn't wanted to do anything. Consumer stated, when patient first came home had real cold and then arm was (incomplete sentence). The outcome of the event fast breathing heartbeat was not recovered and for rest of the events it was unknown.  Information on the lot/Batch number has been requested.
1 day after IZ (MMR, Varicella, Hep A, PREVNAR) localized reaction - red, papular on both thighs; nl colored, fine rash face, abdomen, back 9 days after IZ: fine rash changed to dark red, papular 10 d after IZ.
Information has been received from a registered nurse referring to four patients of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On unknown dates, the patients were vaccinated with ROTATEQ orally (dose, dose number and lot# were not reported), which was improperly stored. No adverse effects were reported. On 19-OCT-2015, a phone call was placed to the registered nurse, who was unable to provide the patient's identifiers at that time. Follow-up information has been received from the registered nurse on 20-OCT-2015. A 11-week-old patient (gender unknown) was vaccinated with improperly stored doses of ROTATEQ lot# K016261, orally and RECOMBIVAX HB lot# L004754 (dose and route not reported), both administered on 31-AUG-2015. This is one of several reports received from the same reporter. Additional information has been requested.
agitation; bone pain in both legs and arms; Gums swelled; Internal inflammation bones; Gums - still painful; extreme fatigue; knee pain; headache for two weeks; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 27Oct2021 23:00 (Batch/Lot number: unknown) at the age of 54 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Epstein-Barr virus" (ongoing); "Asthma" (ongoing), notes: Teens; "Graves Disease" (ongoing), notes: Onset date: 17Apr, managed with acupuncture no results; "Thyroid" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Anatomical location:  Right arm, Route of administration: Intramuscular, Batch/Lot Number: Unable to Locate or Read the Details, Vaccination Time : 2:00 PM), administration date: 07Apr2021, when the patient was 54 years old, for COVID-19 immunization; Bnt162b2 (Dose 2, Anatomical location:  Left arm, Vaccination Time : 2:00 PM, Batch/Lot Number: Unable to Locate or Read the Details), administration date: 27Apr2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious) with onset Oct2021, outcome "recovered" (2021), described as "extreme fatigue"; AGITATION (non-serious) with onset Oct2021, outcome "recovered" (2021), described as "agitation"; ARTHRALGIA (non-serious) with onset Oct2021, outcome "unknown", described as "knee pain"; BONE PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "bone pain in both legs and arms"; HEADACHE (non-serious) with onset Oct2021, outcome "recovered" (2021), described as "headache for two weeks"; GINGIVAL SWELLING (non-serious) with onset Oct2021, outcome "recovering", described as "Gums swelled"; OSTEITIS (non-serious) with onset Oct2021, outcome "unknown", described as "Internal inflammation bones"; GINGIVAL PAIN (non-serious) with onset Oct2021, outcome "not recovered", described as "Gums - still painful". Additional information: Vaccination facility type was Pharmacy or Drug store. No vaccinations Prior (within 4 weeks). Specific relevant test for thromboembolic events with thrombocytopenia and Relevant tests was None. Oct booster extreme fatigue & agitation for a month- Knee pain, bone pain in both legs + arms, headache for two weeks. Gums swollen + red-dentist said due to internal inflammation Bones - hurt 3 months- 90% better Gums - still painful -50% better. I'm afraid of another booster at this point  The lot number for bnt162b2 was not provided and will be requested during follow up.